The VA Center for Strategic Partnerships facilitated the grant, which will use VA’s telehealth infrastructure to allow veterans to access telehealth oncology platforms under Bristol Myers Squibb Foundation’s Cancer Disparities Initiative. Through the partnership, veterans who undergo genetic sequencing will have access to genetic counseling and participation in clinical trials through telehealth.
The teleoncology program will use VA’s Video Connect telehealth platform, which currently conducts more than 20,000 virtual appointments each day, according to the June 3 news release.
VHA and Bristol Myers Squibb and Bristol Myers Squibb Foundation will launch the program at the virtual American Society of Clinical Oncology annual meeting Aug. 8-10.
More articles on oncology:
Enrollment in clinical trials for cancer dropped as COVID-19 cases rose, study shows
Premature cancer deaths among racial minorities cost US economy millions, study shows
Affiliates of top cancer hospitals have lower survival rates, study finds
